×
For best experience we recommend to activate Javascript in your browser.
ERBB3 antibody (N-Term)
This Rabbit Polyclonal antibody specifically detects ERBB3 in WB, IHC, ELISA and FACS. It exhibits reactivity toward Human.
Quick Overview for ERBB3 antibody (N-Term) (ABIN2261644)
Target
See all ERBB3 Antibodies
ERBB3
(Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3))
Reactivity
All reactivities for ERBB3 antibodies
Human
Host
All hosts for ERBB3 antibodies
Rabbit
Clonality
All clonalities for ERBB3 antibodies
Polyclonal
Conjugate
All conjugates for ERBB3 antibodies
This ERBB3 antibody is un-conjugated
Application
All applications for ERBB3 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS)
Product Details anti-ERBB3 Antibody
(hide)
Binding Specificity
All epitopes for ERBB3 antibodies
AA 24-55, N-Term
Cross-Reactivity
Human, Mouse (Murine)
Cross-Reactivity (Details)
Calculated cross reactivity: Hu Mo
Characteristics
ErbB3, NT (Receptor Tyrosine-protein Kinase erbB-3, Proto-oncogene-like Protein c-ErbB-3, Tyrosine Kinase-type Cell Surface Receptor HER3, HER3)
Purification
Purified by ammonium sulfate precipitation.
Immunogen
KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 24-55 in the N-terminal region of human ErbB3, UniProt Accession #P21860.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for ERBB3
(hide)
Target
ERBB3
(Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3))
Alternative Name
ErbB3
UniProt
P21860
Pathways
RTK Signaling , Fc-epsilon Receptor Signaling Pathway , EGFR Signaling Pathway , Neurotrophin Signaling Pathway
Recently viewed
(hide)
Chat with us , powered by LiveChat